| MC 2345 d-Biotin, [thieno[3,4-d]imidazo-carbonyl-14C]- | |
| Click here for Typical Certificate of Analysis | |
|
MORpure™
HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram
|
|
| DMSO solution with 50mM 2-mercaptoethanol, 100 μCi/ml | |
| > 50 mCi(1.85 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
|
M.W. 244.31 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
| MC 2345L d-Biotin, [thieno[3,4-d]imidazo-carbonyl-14C]- | |
|
MORpure™
HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram
|
|
| DMSO solution with 50mM 2-mercaptoethanol, 100 μCi/ml | |
| 30-50 mCi(1.11-1.85 GBq)/mmol |
10 µCi (370 kBq) $1240 |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 244.31 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |